Evidence map›Paper›PMID 36255482›Full record

ArticleEuropean journal of clinical pharmacology2022

Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation.

Nadia Ben-Fredj, Ferdaous Chahed, Najah Ben-Fadhel, Khadija Mansour, Haifa Ben-Romdhane, Randa Said El Mabrouk, Zohra Chadli, Donia Ghedira, Hichem Belhadjali, Amel Chaabane and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Review
  5. Article
  6. New-onset chronic spontaneous urticaria post-COVID-19 vaccination-South African case series.The journal of allergy and clinical immunology. Global · 2023
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Nadia Ben-FredjDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia.
Ferdaous ChahedDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia. dr.ferdaws.chahed@gmail.com.ORCID http://orcid.org/0000-0003-0041-2921
Najah Ben-FadhelDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia.
Khadija MansourDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia.
Haifa Ben-RomdhaneDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia.
Randa Said El MabroukDepartment of Dermatology, University Hospital of Monastir, The University of Monastir, Monastir, Tunisia.
Zohra ChadliDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia.
Donia GhediraDepartment of Chemistry, University Hospital of Monastir, The University of Monastir, Monastir, Tunisia.
Hichem BelhadjaliDepartment of Dermatology, University Hospital of Monastir, The University of Monastir, Monastir, Tunisia.
Amel ChaabaneDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia.
Karim AouamDepartment of Clinical Pharmacology, Faculty of Medicine of Monastir, University Hospital, The University of Monastir, Monastir, Tunisia.
University of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrticaria following the COVID-19 vaccine was rarely reported and had a short self-limited resolution. However, there has been relatively little literature published on CSU induced by COVID-19 vaccines. PURPOSE: We describe a case series of patients who experienced CSU after SARS-CoV-2 vaccination.

methodsA retrospective case series of 10 patients referred to the Department of Clinical Pharmacology of the University of Monastir (January 2021-January 2022) and included for evaluation of urticaria after COVID-19 vaccination.

resultsThe median age was 31 years and patients were mostly female. Atopy was presented in 3 patients and urticaria was accompanied by angioedema in 6 patients. The median time interval between vaccination and the onset of urticaria was 28.5 h. The offended dose was the first one in 8 patients. The resolution of the eruption was observed at least 2 months later, despite the regular use of a full dose of antihistamine in nine patients. Polynuclear leucocytosis was identified in 5 patients. Anti-TPOAb was positive in one patient after receiving the BNT162b2 vaccine. Total serum IgE was elevated in 4 patients. Skin tests for the suspected vaccine as well as the vaccine excipient were negative.

conclusionWe add to the medical literature ten new cases of chronic spontaneous urticarial reactions following COVID-19 vaccines uncontrolled with high-dose first-generation H1 antihistamines.

Indexed as

Chronic UrticariaCOVID-19COVID-19 VaccinesUrticariaAdultBNT162 VaccineChronic DiseaseFemaleHistamine H1 AntagonistsHumansMaleRetrospective StudiesSARS-CoV-2BNT162 VaccineCOVID-19 VaccinesHistamine H1 AntagonistsChronicCOVID-19 vaccinesSARS-CoV-2Side effectsUrticaria

Identifiers

PMID36255482
PMCPMC9579615
OpenAlexW4306729590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.